202 related articles for article (PubMed ID: 31079517)
1. Evaluation of a Community-Based Diabetes Prevention Program in Thailand: A Cluster Randomized Controlled Trial.
Aekplakorn W; Tantayotai V; Numsangkul S; Tatsato N; Luckanajantachote P; Himathongkam T
J Prim Care Community Health; 2019; 10():2150132719847374. PubMed ID: 31079517
[TBL] [Abstract][Full Text] [Related]
2. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial.
Saito T; Watanabe M; Nishida J; Izumi T; Omura M; Takagi T; Fukunaga R; Bandai Y; Tajima N; Nakamura Y; Ito M;
Arch Intern Med; 2011 Aug; 171(15):1352-60. PubMed ID: 21824948
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
Li G; Zhang P; Wang J; An Y; Gong Q; Gregg EW; Yang W; Zhang B; Shuai Y; Hong J; Engelgau MM; Li H; Roglic G; Hu Y; Bennett PH
Lancet Diabetes Endocrinol; 2014 Jun; 2(6):474-80. PubMed ID: 24731674
[TBL] [Abstract][Full Text] [Related]
4. Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community.
Harati H; Hadaegh F; Momenan AA; Ghanei L; Bozorgmanesh MR; Ghanbarian A; Mirmiran P; Azizi F
Am J Prev Med; 2010 Jun; 38(6):628-636.e1. PubMed ID: 20494239
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
Gong Q; Zhang P; Wang J; Ma J; An Y; Chen Y; Zhang B; Feng X; Li H; Chen X; Cheng YJ; Gregg EW; Hu Y; Bennett PH; Li G;
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):452-461. PubMed ID: 31036503
[TBL] [Abstract][Full Text] [Related]
6. Predictors of success of a lifestyle intervention in relation to weight loss and improvement in glucose tolerance among individuals at high risk for type 2 diabetes: the FIN-D2D project.
Rautio N; Jokelainen J; Saaristo T; Oksa H; Keinänen-Kiukaanniemi S; ; Peltonen M; Vanhala M; Korpi-Hyövälti E; Moilanen L; Saltevo J; Niskanen L; Tuomilehto J; Uusitupa M
J Prim Care Community Health; 2013 Jan; 4(1):59-66. PubMed ID: 23799691
[TBL] [Abstract][Full Text] [Related]
7. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
[TBL] [Abstract][Full Text] [Related]
8. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
Gilis-Januszewska A; Lindström J; Tuomilehto J; Piwońska-Solska B; Topór-Mądry R; Szybiński Z; Peltonen M; Schwarz PE; Windak A; Hubalewska-Dydejczyk A
BMC Public Health; 2017 Feb; 17(1):198. PubMed ID: 28202029
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
Florez H; Temprosa MG; Orchard TJ; Mather KJ; Marcovina SM; Barrett-Connor E; Horton E; Saudek C; Pi-Sunyer XF; Ratner RE; Goldberg RB;
Diabetes Obes Metab; 2014 Apr; 16(4):326-33. PubMed ID: 24118860
[TBL] [Abstract][Full Text] [Related]
10. Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.
Davey Smith G; Bracha Y; Svendsen KH; Neaton JD; Haffner SM; Kuller LH;
Ann Intern Med; 2005 Mar; 142(5):313-22. PubMed ID: 15738450
[TBL] [Abstract][Full Text] [Related]
11. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.
Kosaka K; Noda M; Kuzuya T
Diabetes Res Clin Pract; 2005 Feb; 67(2):152-62. PubMed ID: 15649575
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial.
Ramachandran A; Snehalatha C; Ram J; Selvam S; Simon M; Nanditha A; Shetty AS; Godsland IF; Chaturvedi N; Majeed A; Oliver N; Toumazou C; Alberti KG; Johnston DG
Lancet Diabetes Endocrinol; 2013 Nov; 1(3):191-8. PubMed ID: 24622367
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of digital health using the transtheoretical model to prevent or delay type 2 diabetes in impaired glucose tolerance patients: protocol for a randomized control trial.
Alzeidan R; Shata Z; Hassounah MM; Baghdadi LR; Hersi A; Fayed A; Kashour T; Elmorshedy H
BMC Public Health; 2019 Nov; 19(1):1550. PubMed ID: 31752774
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a virtual assistance-based lifestyle intervention in reducing risk factors for Type 2 diabetes in young employees in the information technology industry in India: LIMIT, a randomized controlled trial.
Limaye T; Kumaran K; Joglekar C; Bhat D; Kulkarni R; Nanivadekar A; Yajnik C
Diabet Med; 2017 Apr; 34(4):563-568. PubMed ID: 27589695
[TBL] [Abstract][Full Text] [Related]
15. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project.
Laatikainen T; Dunbar JA; Chapman A; Kilkkinen A; Vartiainen E; Heistaro S; Philpot B; Absetz P; Bunker S; O'Neil A; Reddy P; Best JD; Janus ED
BMC Public Health; 2007 Sep; 7():249. PubMed ID: 17877832
[TBL] [Abstract][Full Text] [Related]
16. A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program.
Thankappan KR; Sathish T; Tapp RJ; Shaw JE; Lotfaliany M; Wolfe R; Absetz P; Mathews E; Aziz Z; Williams ED; Fisher EB; Zimmet PZ; Mahal A; Balachandran S; D'Esposito F; Sajeev P; Thomas E; Oldenburg B
PLoS Med; 2018 Jun; 15(6):e1002575. PubMed ID: 29874236
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials.
Yoon U; Kwok LL; Magkidis A
Metabolism; 2013 Feb; 62(2):303-14. PubMed ID: 22959500
[TBL] [Abstract][Full Text] [Related]
18. Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance.
Sakane N; Sato J; Tsushita K; Tsujii S; Kotani K; Tsuzaki K; Tominaga M; Kawazu S; Sato Y; Usui T; Kamae I; Yoshida T; Kiyohara Y; Sato S; Kuzuya H;
BMC Public Health; 2011 Jan; 11(1):40. PubMed ID: 21235825
[TBL] [Abstract][Full Text] [Related]
19. Effects of a culturally adapted lifestyle intervention on cardio-metabolic outcomes: a randomized controlled trial in Iraqi immigrants to Sweden at high risk for Type 2 diabetes.
Siddiqui F; Kurbasic A; Lindblad U; Nilsson PM; Bennet L
Metabolism; 2017 Jan; 66():1-13. PubMed ID: 27923444
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
